Back to search

Ireland· IE-PA-EU/1/22/1699/004

Qdenga powder and solvent for solution for injection

A dengue-virus-impfstoffe product, registered in Ireland by Takeda Pharmaceuticals International AG Ireland Branch. The same ATC class is registered in 10 of our 19 countries.

ATC J07BX04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedQdenga powder and solvent for solutio…ATCJ07BX04REGISTER NO.IE-PA-EU/1/22/1699/004PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Dengue-virus-impfstoffe is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BX04 (dengue-virus-impfstoffe), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Dengue-virus-impfstoffe · ATC J07BX04

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Manufacturer
Takeda Pharmaceuticals International AG Ireland Branch
Country
Ireland (IE)
ATC code
J07BX04
ATC class
Dengue-Virus-Impfstoffe
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/22/1699/004

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad56213c-356d-4951-8430-3c321b9a2db5
GET /v1/drugs/ad56213c-356d-4951-8430-3c321b9a2db5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection",
  "routes": [
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J07B",
    "J07BX04"
  ],
  "strength": null,
  "pa_number": "EU/1/22/1699/004",
  "substances": [
    "Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated",
    "Dengue virus, serotype 2, live, attenuated",
    "Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated",
    "Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "05/12/2022",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about dengue-virus-impfstoffe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.